gesjGEOGRAPHY, ENVIRONMENT, SUSTAINABILITYGEOGRAPHY, ENVIRONMENT, SUSTAINABILITY2071-93882542-1565Russian Geographical Society10.24057/2071-9388-2020-202gesj-1712Research ArticleREGULAR ISSUEThe Distribution And Typological Classification Of Incidence/Mortality Rates And Dynamics Of Tuberculosis In Russia, 2006–2017MalkhazovaSvetlana

Moscow

ShartovaNatalia

Moscow

GaidaRazia

Port Elizabeth

DavidsAdlai

Port Elizabeth

TikunovVladimir

Moscow

OrlovDmitry

Moscow

orlovmsu@gmail.comLomonosov Moscow State UniversityRussian FederationHuman Sciences Research Council; Nelson Mandela UniversitySouth Africa202105042021141241250Copyright © Malkhazova S., Shartova N., Gaida R., Davids A., Tikunov V., Orlov D., 20212021Malkhazova S., Shartova N., Gaida R., Davids A., Tikunov V., Orlov D.Malkhazova S., Shartova N., Gaida R., Davids A., Tikunov V., Orlov D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ges.rgo.ru/jour/article/view/1712

Despite the achieved success in the fight against tuberculosis, the disease remains an immediate problem for a number of countries including Russia. To a large extent, the reasons for the high incidence and mortality of the population are not only medical but also social in nature, which leads to the emergence of geographical patterns in the spread of the disease. The purpose of the study is to identify the spatio-temporal conditions that shape the epidemiological situation of tuberculosis in Russia at both the national and regional levels. Using GIS technologies, an analysis of the current spread of the infection in the Russian Federation was carried out based on data for the period from 2006 through 2017. Typological classification of regions according to the dynamics and magnitude of the incidence rate has been developed. Based on the cartographic analysis that was carried out, regions with the most unfavorable tuberculosis situation in the Russian Federation were identified for a more detailed study at the municipal level.

tuberculosisRussiamappingspatial analysistypological classificationdynamics of incidence and mortalityThe reported study was funded by Russian Foundation for Basic Research (RFBR) and National Research Foundation (NFR) (South Africa) according to the research project № 19-55-60003, by RFBR according to the research project № 18-05-60037 and by NRF according to the research project №118913 with reference number RUSA180626348966. Dmitry Orlov was partly supported by Moscow State University Grant for Leading Scientific Schools «Depository of the Living Systems» within the MSU Development Program.ReferencesAlsultan A., Peloquin C.A. (2014). Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update. Drugs 74, 839-854, DOI: 10.1007/s40265-014-0222-8.Alsultan A., Peloquin C.A. (2014). Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update. Drugs 74, 839-854, DOI: 10.1007/s40265-014-0222-8.Barkanova O.N., Gagarina S.G., Kaluzhenina A.A., Popkova N.L. (2018). Modern drug-resistant pulmonary tuberculosis. Bulletin of the Volgograd State Medical University, 1(65), 23-25.Barkanova O.N., Gagarina S.G., Kaluzhenina A.A., Popkova N.L. (2018). Modern drug-resistant pulmonary tuberculosis. Bulletin of the Volgograd State Medical University, 1(65), 23-25.Berry M., Blankley S., Graham C., Bloom C., O’Garra A. Systems approaches to studying the immune response in tuberculosis. Current Opinion in Immunology, 25(5), October 2013, 579-587, DOI: 10.1016/j.coi.2013.08.003.Berry M., Blankley S., Graham C., Bloom C., O’Garra A. Systems approaches to studying the immune response in tuberculosis. Current Opinion in Immunology, 25(5), October 2013, 579-587, DOI: 10.1016/j.coi.2013.08.003.Central Research Institute for Health Organization and Informatization of the Ministry of Health of the Russian Federation.https://mednet.ru/informatizatsiya/tsentr-monitoringa-tuberkuleza#h11-analiticheskie-obzory) [Accessed 15.10.2020].Central Research Institute for Health Organization and Informatization of the Ministry of Health of the Russian Federation.https://mednet.ru/informatizatsiya/tsentr-monitoringa-tuberkuleza#h11-analiticheskie-obzory) [Accessed 15.10.2020].Chung-Delgado K, Guillen-Bravo S, RevillaMontag A, Bernabe-Ortiz A (2015). Mortality among MDR-TB Cases: Comparison with DrugSusceptible Tuberculosis and Associated Factors. PLoS ONE 10(3): e0119332, DOI: 10.1371/journal.pone.0119332.Chung-Delgado K, Guillen-Bravo S, RevillaMontag A, Bernabe-Ortiz A (2015). Mortality among MDR-TB Cases: Comparison with DrugSusceptible Tuberculosis and Associated Factors. PLoS ONE 10(3): e0119332, DOI: 10.1371/journal.pone.0119332.Everitt B., Skrondal A. (2010). «Standardized mortality rate (SMR)». The Cambridge dictionary of statistics. New York: Cambridge University Press, 409.Everitt B., Skrondal A. (2010). «Standardized mortality rate (SMR)». The Cambridge dictionary of statistics. New York: Cambridge University Press, 409.Girum T., Muktar E., Lentiro K., Wondiye H., Shewangizaw M. (2018). Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines, 4(5), Published online 2018 Jun 14, DOI: 10.1186/s40794-018-0065-5.Girum T., Muktar E., Lentiro K., Wondiye H., Shewangizaw M. (2018). Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines, 4(5), Published online 2018 Jun 14, DOI: 10.1186/s40794-018-0065-5.Global tuberculosis report (2020). WHO, 208.Global tuberculosis report (2020). WHO, 208.Healthcare in Russia (2019). Statistical collection / Rosstat, Moscow, 2019, 170.Healthcare in Russia (2019). Statistical collection / Rosstat, Moscow, 2019, 170.Hosseinipour M.C. et al. (2016). Empiric Tuberculosis Therapy versus Isoniazid in Advanced HIV-infected Adult Outpatients Initiating Antiretroviral Therapy: a Multi-Country Randomized Controlled Trial.Lancet, 387(10024): 1198-1209, DOI: 10.1016/S0140-6736(16)00546-8.Hosseinipour M.C. et al. (2016). Empiric Tuberculosis Therapy versus Isoniazid in Advanced HIV-infected Adult Outpatients Initiating Antiretroviral Therapy: a Multi-Country Randomized Controlled Trial.Lancet, 387(10024): 1198-1209, DOI: 10.1016/S0140-6736(16)00546-8.Krasnov V.A., Revyakina O.V., Filimonov P.N., Stepanov D.V. (2016). Tuberculosis: general patterns of the epidemic process in Russia and beyond the Urals. Tuberculosis and lung diseases, 94(10): 5-11, DOI: 10.21292/2075-1230-2016-94-10-5-11.Krasnov V.A., Revyakina O.V., Filimonov P.N., Stepanov D.V. (2016). Tuberculosis: general patterns of the epidemic process in Russia and beyond the Urals. Tuberculosis and lung diseases, 94(10): 5-11, DOI: 10.21292/2075-1230-2016-94-10-5-11.Lee J.Y. (2015). Diagnosis and Treatment of Extrapulmonary Tuberculosis. TubercRespir Dis (Seoul), 78(2): 47-55, DOI: 10.4046/trd.2015.78.2.47.Lee J.Y. (2015). Diagnosis and Treatment of Extrapulmonary Tuberculosis. TubercRespir Dis (Seoul), 78(2): 47-55, DOI: 10.4046/trd.2015.78.2.47.Lyon S., Rossman M. (2017). Pulmonary Tuberculosis, p 285-298. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Seventh Edition. ASM Press, Washington, DC, DOI: 10.1128/microbiolspec.TNMI7-0032-2016.Lyon S., Rossman M. (2017). Pulmonary Tuberculosis, p 285-298. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Seventh Edition. ASM Press, Washington, DC, DOI: 10.1128/microbiolspec.TNMI7-0032-2016.Manina V.V., Starshinova A.A., Panteleev A.M. (2017). Tuberculosis and HIV infection: the epidemic situation in Russia and the world over the past ten years, the specifics of detection and diagnosis. HIV infection and immunosuppression, 9(4): 7-16, DOI: 10.22328/2077-98282017-9-4-7-16.Manina V.V., Starshinova A.A., Panteleev A.M. (2017). Tuberculosis and HIV infection: the epidemic situation in Russia and the world over the past ten years, the specifics of detection and diagnosis. HIV infection and immunosuppression, 9(4): 7-16, DOI: 10.22328/2077-98282017-9-4-7-16.Mbu E.T., Sauter F., Zoufaly A., BronsvoortBMdC, Morgan K.L., Noeske J. et al. (2018). Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes. PLoS ONE 13(6): e0199634, DOI: 10.1371/journal.pone.0199634.Mbu E.T., Sauter F., Zoufaly A., BronsvoortBMdC, Morgan K.L., Noeske J. et al. (2018). Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes. PLoS ONE 13(6): e0199634, DOI: 10.1371/journal.pone.0199634.Nechaeva O.B. (2018). Epidemic situation on tuberculosis in Russia // Tuberculosis and lung diseases, 96(8), 15-24.Nechaeva O.B. (2018). Epidemic situation on tuberculosis in Russia // Tuberculosis and lung diseases, 96(8), 15-24.Shelkova E.S., Romanenko V.V. (2013). Tuberculosis – yesterday, today, tomorrow. Ural Medical Journal, 9,110-120.Shelkova E.S., Romanenko V.V. (2013). Tuberculosis – yesterday, today, tomorrow. Ural Medical Journal, 9,110-120.The End TB Strategy (2014). WHO, 20.The End TB Strategy (2014). WHO, 20.Tikunov V.S. (1997). Classifications in geography: renaissance or fading? Smolensk: SSU.Tikunov V.S. (1997). Classifications in geography: renaissance or fading? Smolensk: SSU.Vasilyeva I.A., Belilovsky E.M., Borisov S.E., Sterlikov S.A. (2017). Multidrug-resistant tuberculosis in the countries of the world and the Russian Federation // Tuberculosis and lung diseases, 95(11), 5-17, DOI: 10.21292/2075-1230-2017-95-11-5-17.Vasilyeva I.A., Belilovsky E.M., Borisov S.E., Sterlikov S.A. (2017). Multidrug-resistant tuberculosis in the countries of the world and the Russian Federation // Tuberculosis and lung diseases, 95(11), 5-17, DOI: 10.21292/2075-1230-2017-95-11-5-17.

The authors declare that there are no conflicts of interest present.